Compare Intuitive Surgical, Inc. (ISRG) vs Schwab US Large Cap Growth ETF (SCHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs Schwab US Large Cap Growth ETF — how do they compare? Intuitive Surgical, Inc. trades at $423.96 (market cap $146.76B), while Schwab US Large Cap Growth ETF trades at $36.74 (market cap $65.01B). The key difference: Intuitive Surgical, Inc. is far larger — about 2.3× Schwab US Large Cap Growth ETF's market cap, and Schwab US Large Cap Growth ETF is trading nearer its 52-week high, Intuitive Surgical, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and Schwab US Large Cap Growth ETF for 50 Days on average.
| ISRG | SCHG | |
|---|---|---|
Market Cap | $146.76B | $65.01B |
Volume | 2,529,814 | 8,554,399 |
Sector | Health | Sector/Thematic |
52-Week High | $592.85 | $36.93 |
52-Week Low | $332.02 | $28.10 |
Typical Hold Time | 84 Days | 50 Days |
Enterprise Value | $141.54B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $415.41, up 0.21% with a bullish technical outlook. The stock shows strong fundamentals with 2025 revenue of $10.06B and net income of $2.86B, maintaining consistent earnings beats. Valuation metrics remain elevated with a P/E of 47.64 and P/S of 13.54, reflecting premium pricing for the robotic surgery leader. Recent news highlights international expansion in India and Japan to offset China weakness, while da Vinci 5 upgrades and ASC market penetration drive growth.
ISRG presents a compelling growth story with dominant market position and expanding global footprint, though premium valuation requires sustained execution. Key risks include procedure growth moderation and competitive pressures. Analyst consensus remains strongly bullish with $480.78 price target representing 16% upside potential from current levels.
SCHG trades at $36.42, down 1.22% on the day, with a bullish technical signal from moving averages despite neutral oscillators. The ETF maintains strong institutional interest as a low-cost large-cap growth vehicle, though concentration in top holdings remains a structural consideration. Recent news highlights SCHG's competitive positioning against peers like VUG and QQQM.
Outlook remains positive given growth stock momentum and SCHG's track record, though investors face concentration risk in mega-cap holdings and potential valuation pressures if growth expectations moderate. The 0.03% expense ratio provides cost advantage in the large-cap growth ETF space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About Schwab US Large Cap Growth ETF
SCHG is an ETF that seeks to track the total return of the Dow Jones U.S. Large-Cap Growth Total Stock Market Index. The fund provides low-cost exposure to a diversified portfolio of large-capitalization U.S. companies that are classified as growth stocks based on factors such as sales, earnings, and book value growth rates. SCHG is often used by investors seeking long-term capital appreciation from market-leading companies with above-average growth potential.
Read more on SCHG →
